The U.S. cannabis industry remains on a strong growth path, with projections estimating a $45 billion market in 2025. More than 20 states now allow adult recreational cannabis use, while others continue expanding medical programs. Recently, lawmakers have debated cannabis reform at the federal level, including rescheduling cannabis to a lower-risk drug classification. This shift could bring major tax relief and open new financial opportunities for cannabis companies. Despite challenges, these changes are fueling optimism across the sector. Penny stocks in this space offer low entry prices and potential for large percentage gains. As the market responds to legislative updates, investor attention has increased on smaller-cap cannabis plays with aggressive growth plans.

Although these stocks carry promise, they also come with significant risks. Many are highly volatile and trade with low daily volume. For this reason, using technical analysis is crucial when watching or trading marijuana penny stocks. Traders should examine key support and resistance levels. It is also smart to use volume indicators and trend confirmation tools. Setting stop-loss orders and managing position sizes can reduce exposure to large losses. Since these stocks can react sharply to news, disciplined entries and exits are essential. Investors must stay alert, follow news catalysts, and apply sound risk strategies. With the right tools and timing, opportunities in marijuana penny stocks can be substantial.

U.S. Cannabis Stocks to Add to Your Radar Now

As the U.S. cannabis industry continues expanding, investors are closely watching select leaders in the sector. In addition, more states are pushing for legalization, which adds to investor optimism. As a result, top-performing marijuana companies are gaining momentum in the market. This article focuses on three U.S. marijuana stocks worth watching in May 2025: Planet 13 Holdings (PLNH), Glass House Brands (GLASF), and Cresco Labs (CRLBF).

Each of these companies has a strong presence in key U.S. markets. They also continue to evolve operationally while navigating regulatory developments. Despite short-term volatility, these stocks have shown resilience and potential for long-term growth. Below is a closer look at each of these top cannabis players, their U.S. dispensary presence, and their latest financial performance.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Top U.S. Marijuana Stocks to Watch in May 2025

1. Planet 13 Holdings Inc. (OTC: PLNH)
2. Glass House Brands Inc. (OTC: GLASF)
3. Cresco Labs Inc. (OTC: CRLBF)

Planet 13 Holdings Inc. (PLNH)

Planet 13 Holdings is best known for operating the largest cannabis dispensary in the world. This flagship location is in Las Vegas, Nevada, and spans over 112,000 square feet. The store offers a unique retail experience that blends cannabis shopping with interactive entertainment. Tourists and locals alike visit the store daily, making it a high-traffic location.

The company has also expanded into Florida, which remains one of the fastest-growing medical cannabis markets. Currently, Planet 13 operates 30 dispensaries throughout Florida. It also has one location in Illinois, bringing its total count to 32 dispensaries. Its expansion strategy focuses on large-scale stores in high-demand regions. This allows the company to maintain brand recognition and customer loyalty.

With its growing footprint and strong consumer appeal, Planet 13 remains one of the most prominent names in the cannabis industry. Its multi-state operations continue to drive future growth opportunities.

Latest Financials

In its most recent quarterly report, Planet 13 posted revenue of $28 million. This marked a notable increase from the prior year’s results. The rise in revenue was largely driven by sales in Florida and continued strength in Las Vegas. Gross profits came in at $12 million, with a gross margin just above 42 percent.

Despite solid revenue growth, the company reported a net loss of $2 million. This was due to higher operating expenses tied to expansion efforts. Its adjusted EBITDA showed a loss of $2.5 million. However, management emphasized that short-term losses were strategic. The focus remains on building long-term value through market growth.

Planet 13 has sufficient liquidity to support future investments. Management is optimistic about Florida’s contribution to revenue in future quarters. Overall, the company is positioning itself for improved profitability as it scales.

[Read More] Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025

Glass House Brands Inc. (GLASF)

Glass House Brands is a vertically integrated cannabis company based in California. The company focuses exclusively on operations within the state. It operates greenhouse cultivation, manufacturing, distribution, and retail stores. This end-to-end control gives the company strong cost advantages.

The company has multiple dispensaries under its Farmacy brand. Most of these stores are located in high-traffic areas in Southern California. In total, Glass House operates eight dispensaries throughout the state. The company is known for its high-quality, sun-grown cannabis. Its cultivation facilities are among the largest in the country.

Glass House continues to expand its greenhouse capacity. This allows it to scale production without significantly increasing costs. The company’s strategy is rooted in operational efficiency and product consistency. As a result, it has become a leader in California’s highly competitive cannabis market. Its premium brand is well recognized by both medical and recreational consumers.

Latest Financials

In its latest earnings report, Glass House generated $44.8 million in revenue, a strong year-over-year increase driven by volume growth. Seasonal demand fluctuations and wholesale pricing pressures impacted the company’s performance, but it managed to maintain growth in core retail locations.

Gross margins remained relatively stable compared to the prior quarter. However, net losses were reported due to temporary increases in labor and facility costs. Management continues to emphasize its commitment to cost control. The company is also investing in automation to enhance productivity.

Cash reserves remain healthy and support ongoing expansion plans. While short-term headwinds persist in the California market, Glass House maintains its long-term bullish outlook. Its large cultivation assets provide a strong advantage. The company believes scale and quality will drive future margins. Therefore, investors continue to monitor Glass House as a top West Coast player.

[Read More]  These Cannabis Stocks Could Pay Off Big In The Future

Cresco Labs Inc. (CRLBF)

Cresco Labs is a multi-state cannabis operator based in Chicago, Illinois. The company is vertically integrated and offers products across nine key U.S. states. Its retail presence includes states like Florida, Illinois, Pennsylvania, and Massachusetts. Cresco Labs markets its dispensaries under the “Sunnyside” brand.

As of May 2025, Cresco operates 71 dispensaries across six states. Its stores are strategically located in both high-density urban centers and suburban areas. The company also owns several well-known consumer cannabis brands. These brands cater to a wide range of user preferences.

Cresco Labs has focused heavily on market depth rather than broad expansion. It prioritizes establishing strong brand loyalty in each region. This approach allows for efficient scaling and better customer service. The company’s mission is to normalize cannabis use through consistent and professional experiences. Cresco remains one of the largest cannabis companies by retail footprint in the U.S.

Latest Financials

Cresco Labs has delayed the release of its Q1 2025 earnings. However, previous performance trends provide some insight. In its last reported quarter, the company generated revenue of over $190 million, supported by strong retail performance in Florida and Illinois.

Gross profit margins hovered around 50 percent, consistent with prior quarters. The company previously reported a net loss, largely due to one-time restructuring costs. However, the adjusted EBITDA remained positive, showing that the business is generating operating cash flow.

Management has reaffirmed its commitment to reducing costs and improving margins. It is also working to optimize its supply chain. The delayed report is expected to include updates on the restructuring’s progress. Despite short-term challenges, Cresco remains financially stable. It continues to focus on market leadership in limited-license states.

U.S. Cannabis Stocks Catching Investor Attention This Week

In conclusion, the U.S. cannabis sector remains a dynamic and evolving space filled with both risk and opportunity. As legalization efforts continue across the country, investor interest in marijuana stocks is expected to grow. Companies like Planet 13, Glass House Brands, and Cresco Labs are positioning themselves for long-term success through strategic expansion and brand development. However, due to market volatility, it is essential to apply technical analysis and manage risk carefully.

Monitoring price action, volume, and key levels can help identify smarter entry points. Setting stop-losses and staying informed on regulatory changes will also support better decision-making. With proper research and a disciplined approach, investors can capitalize on momentum in this exciting sector. As always, focus on strong fundamentals, clear trends, and market-moving news to maximize cannabis-related opportunities. Now is the time to watch these top marijuana stocks as the U.S. industry moves toward broader acceptance.

The post Top Performing U.S. Marijuana Stocks to Watch in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to gain momentum as more states legalize marijuana for recreational and medical use. As of this week, over 20 states now allow adult-use cannabis, and more states are actively exploring legislation. The market is expected to reach over $45 billion in total value by 2025. This sustained growth creates new opportunities for investors looking to enter the space. Recently, there has been renewed discussion about federal reform. Lawmakers are revisiting cannabis rescheduling and expanding access to banking for cannabis businesses. These headlines have sparked renewed interest in marijuana stocks. As a result, traders are now watching several U.S. cannabis companies that could benefit from regulatory momentum.

However, identifying strong opportunities requires more than reading the news. Technical analysis is essential when evaluating short-term entries in volatile sectors like cannabis. Traders should look for patterns, volume spikes, and key support levels. It’s also critical to use proper risk management. Stop losses, trade sizing, and clear entry targets can help limit downside. Even the strongest chart setup can fail without discipline. As the week unfolds, combining these strategies with a solid watchlist may help traders stay focused and avoid emotional decision-making.

In May 2025, investors will continue searching for companies with strong growth potential, strategic positioning, and improving financials. Three marijuana stocks stand out this month: Glass House Brands Inc. (GLASF), The Cannabist Company Holdings Inc. (CBSTF), and Ascend Wellness Holdings Inc. (AAWH). Each company brings unique strengths to the table, including strong retail footprints, cultivation capabilities, and innovative branding. Below is a detailed breakdown of each company’s market presence and financial performance.

[Read  More]  Best Cannabis Penny Stocks to Add to Your May 2025 Watchlist

Top U.S. Marijuana Stocks to Watch in May 2025

1. Glass House Brands Inc. (OTC: GLASF)
2. The Cannabist Company Holdings Inc. (OTC: CBSTF)
3. Ascend Wellness Holdings Inc. (OTC: AAWH)

Glass House Brands Inc. (GLASF)

Glass House Brands Inc. is a vertically integrated cannabis company based in California. The company owns and operates several dispensaries across the state under various banners, including The Farmacy and Natural Healing Center. One of its most notable assets is a massive greenhouse cultivation facility located in Ventura County. This facility is among the largest in the United States, spanning over five million square feet. The company uses this facility to produce high-quality cannabis at scale.

Currently, Glass House operates more than a dozen dispensaries across California. The company’s primary focus remains on the California adult-use market, where it sees significant long-term opportunity. By combining large-scale cultivation with branded retail outlets, Glass House continues to build its presence in one of the most competitive cannabis markets in the U.S. Additionally, its retail strategy includes premium positioning and community-focused stores that appeal to both newcomers and experienced users.

Financially, Glass House has made considerable progress. In recent quarters, the company posted year-over-year revenue growth, driven by an increase in both wholesale and retail sales. The company has also focused on reducing its cost per pound of production. By operating its large-scale greenhouse efficiently, it has improved margins significantly. This focus on cost control has helped the company generate positive adjusted EBITDA in recent quarters.

Additionally, Glass House expects continued growth throughout 2025. Management has projected increased output from its cultivation facility and additional store openings. These developments are expected to drive revenue to new highs. The company is also investing in branded product lines, which offer higher margins and stronger customer loyalty. Despite challenges in the California market, Glass House remains well-positioned due to its scale and brand strength.

[Read More] Top Cannabis REITs to Watch for High Dividends and Long-Term Growth in 2025

The Cannabist Company Holdings Inc. (CBSTF)

The Cannabist Company Holdings Inc., formerly known as Columbia Care, is a multi-state operator with a wide footprint across the U.S. The company operates dispensaries under the Cannabist brand in both medical and adult-use markets. It is currently active in 14 states and manages nearly 100 facilities. This includes more than 70 dispensaries and over 20 cultivation and processing centers. The Cannabist brand aims to deliver a premium cannabis experience to consumers through innovative retail design and curated product offerings.

The company’s largest presence includes states like Florida, New York, and Virginia. It serves both medical patients and recreational customers with a broad selection of flower, edibles, tinctures, and concentrates. Additionally, it owns and distributes several in-house brands. These include Seed & Strain, Triple Seven, and Hedy, each targeting different consumer segments. Through its wide reach and vertical integration, the Cannabist Company seeks to maximize efficiencies and build brand recognition nationwide.

On the financial side, the company has faced some recent headwinds. Revenue saw a modest decline year-over-year due to regulatory delays and pricing pressure in several markets. However, the company has taken action to improve its balance sheet. Management has focused on debt restructuring and improving operational efficiencies. The extension of certain credit terms has allowed the company to reduce financial pressure and plan more effectively for long-term growth.

Although margins tightened slightly in 2024, cost-cutting measures and better inventory management have helped stabilize earnings. Additionally, management is targeting future profitability through improved dispensary performance and streamlined operations. As new adult-use markets open and regulations ease, the Cannabist Company may be well-positioned to regain revenue momentum. It remains a stock to watch closely, especially if broader cannabis reform gains traction at the federal level.

[Read More] 3 Marijuana Stocks For The Long-Term Investing

Ascend Wellness Holdings Inc. (AAWH)

Ascend Wellness Holdings Inc. is another top-tier cannabis operator with a strong footprint in limited-license states. The company operates in seven states: Illinois, Massachusetts, Michigan, New Jersey, Ohio, Pennsylvania, and Maryland. Ascend owns and operates cultivation facilities, processing centers, and over 30 retail dispensaries across these markets. The company is known for its vertically integrated structure and diverse product portfolio, which includes edibles, concentrates, flower, and vapes.

Ascend’s retail strategy focuses on high-traffic locations and premium store layouts. The company’s in-house brands include Ozone and Simply Herb. These brands cater to both value-conscious customers and those seeking premium products. Ascend also has a strong wholesale operation, supplying products to third-party dispensaries in addition to its own stores. The company’s strategic positioning in high-growth, tightly regulated markets gives it a competitive edge.

From a financial perspective, Ascend has delivered consistent top-line growth. In 2024, the company posted an annual revenue increase compared to the prior year. This growth was supported by new store openings and increased cultivation yields. However, like many cannabis operators, Ascend reported a net loss as it continued to invest in infrastructure and expansion. Despite this, management emphasized a strong focus on achieving profitability through margin improvements and operating leverage.

The company also initiated a share repurchase program in late 2024. This was seen as a sign of management’s confidence in long-term value creation. In 2025, Ascend is expected to continue expanding in New Jersey and Maryland, where adult-use markets are gaining traction. These expansions could significantly boost revenue and brand visibility. With disciplined growth and operational improvements underway, Ascend remains a strong candidate for long-term investors in the cannabis sector.

[Read More] These 3 Marijuana Stocks Could Be The Winners You Need

Capitalizing on Cannabis Gains: Investment Approaches Post-Upside

As the U.S. marijuana industry matures, companies with strong fundamentals and strategic market positions are beginning to emerge as clear leaders. Glass House Brands, The Cannabist Company, and Ascend Wellness each offer a different path to growth. Whether through large-scale cultivation, nationwide branding, or disciplined state expansion, these companies are positioned to capitalize on the evolving regulatory and consumer landscape. For investors looking at cannabis exposure in May 2025, these three stocks are well worth a spot on the watchlist.

The post Cannabis Stocks on the Rise: Key Players to Watch Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry is expanding rapidly, with projections suggesting it could surpass $75 billion in value by 2030. This growth is fueled by rising consumer demand, expanding legalization, and increased acceptance of medical cannabis. Recently, lawmakers introduced new legislation that could pave the way for federal cannabis reform. This has reignited investor interest in marijuana-related stocks, especially low-cost options. As the regulatory environment evolves, these penny stocks are drawing attention for their high-reward potential.

Marijuana penny stocks typically trade below $5 per share. They can offer fast gains but also carry elevated risks. Therefore, technical analysis becomes essential. Tools like moving averages and RSI help identify momentum shifts. Traders also watch support and resistance zones for trade setups. Risk management is equally important. Setting stop-loss orders and position sizing are key to protecting capital. In this fast-moving sector, staying disciplined can help turn volatility into opportunity.

The U.S. cannabis industry is expanding rapidly as legalization efforts continue. Investors are turning their attention to marijuana stocks showing strong fundamentals and operational growth. In April 2025, three standout companies include Glass House Brands Inc. (GLASF), Cansortium Inc. (CNTMF), and Ascend Wellness Holdings Inc. (AAWH). Each company offers strategic advantages, growing footprints, and compelling financial stories. With demand for cannabis increasing and regulatory reform underway, these stocks deserve a closer look.

[Read More] 2 Marijuana Stocks To Consider For Long-Term Investing

Top 3 Marijuana Stocks to Watch in April 2025

1. Glass House Brands Inc. (OTC: GLASF)
2. Cansortium Inc. (OTC: CNTMF)
3. Ascend Wellness Holdings Inc. (OTC: AAWH)

Glass House Brands Inc. (GLASF)

Glass House Brands is based in California and focuses on cultivating, manufacturing, and distributing cannabis products. It has become one of the largest vertically integrated cannabis companies in the state. The company emphasizes sustainable, environmentally friendly growing techniques. It owns one of the largest greenhouse operations dedicated to cannabis cultivation in the U.S.

As of April 2025, Glass House operates five dispensaries across California. These locations include cities like Los Angeles, Santa Barbara, and Berkeley. The company targets both wholesale and retail segments, supplying dispensaries and direct consumers alike. Its strong presence in California gives it access to the country’s largest legal cannabis market.

Financially, Glass House continues to show year-over-year growth. In 2024, it significantly increased biomass output, helping drive higher revenue. It projects biomass production to increase by over 25% this year. Additionally, full-year revenue is expected to grow by more than 10%.

Adjusted EBITDA nearly doubled in the most recent quarter. Profit margins also improved due to cost reductions and operational efficiencies. Overall, the company is on track for a profitable year, driven by strategic expansion and production scale. Investors see Glass House as a dominant California brand with national growth potential.

[Read More] April 2025’s Canadian Cannabis Stock Picks: Growth and Opportunity

Cansortium Inc. (CNTMF)

Cansortium Inc. operates under the brand name FLUENT. It is a vertically integrated cannabis company focused on quality cultivation and retail services. The company is headquartered in Miami, Florida, and serves several key U.S. markets. Cansortium is known for its medical cannabis operations and dedication to customer experience.

Its largest footprint is in Florida, where it runs dozens of dispensaries. Additional operations extend into Pennsylvania and Texas. The company focuses on creating consistent, premium cannabis products. As of April 2025, it manages 28 dispensary locations across the country.

Cansortium’s financial performance reflects its disciplined approach. The company has maintained stable operations despite pricing pressures in Florida. While its stock price remains below one dollar, it continues to attract attention for long-term growth. Cost controls and streamlined operations have helped reduce cash burn.

Though revenue has remained relatively flat, gross margins have shown improvement. The company remains committed to profitability, even in a challenging environment. By focusing on core markets and operational efficiency, Cansortium aims to return to growth in the second half of the year.

[Read More] Top Ancillary Marijuana Stocks For The Diversified Investors

Ascend Wellness Holdings Inc. (AAWH)

Ascend Wellness is a multi-state operator with assets across several eastern U.S. states. The company is based in New York and holds cultivation, processing, and retail licenses. Its markets include Illinois, Michigan, New Jersey, Massachusetts, Ohio, and Pennsylvania. Ascend targets both adult-use and medical cannabis consumers.

The company currently operates 35 dispensaries and seven cultivation facilities. It has established a strong brand in states like Illinois and New Jersey. Ascend’s vertically integrated model supports supply chain control and higher profit margins. Its premium product lines are sold across retail and wholesale channels.

In 2024, Ascend posted strong financials. Total annual revenue increased to over $560 million, driven by wholesale growth. Third-party wholesale sales surged nearly 30%, supporting top-line expansion. Retail sales held steady, despite market saturation in some states.

Adjusted gross profit reached over $225 million, with margins improving year-over-year. The company ended the year with nearly $90 million in cash, giving it flexibility for future investments. Ascend continues to optimize operations while expanding its geographic footprint. It remains well-positioned for further growth in 2025 and beyond.

Undervalued Cannabis Stocks Ready to Rebound

To begin with, these three companies—Glass House Brands, Cansortium, and Ascend Wellness—each offer a unique value proposition in the evolving cannabis sector. Moreover, their strong operational strategies, expanding footprints, and disciplined financials make them top marijuana stocks to watch in April 2025. As a result, they are well-positioned to benefit from renewed momentum in the industry. Looking ahead, as investor interest returns to cannabis, these names could very well lead the next wave of growth.

The post Top U.S. Pot Stocks for Growth in April 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to grow rapidly, creating opportunities for investors focused on penny stocks. In 2024, legal cannabis sales topped $32 billion nationwide. That number is expected to reach $45 billion by the end of 2025. This growth is fueled by new state-level legalization and rising consumer demand. Currently, adult-use cannabis is legal in nearly half the U.S. states. Even more importantly, recent headlines hint at changes at the federal level. A proposal to reclassify marijuana under federal law could ease restrictions on the industry. As a result, many investors are turning their attention to low-priced marijuana stocks. These companies often react quickly to news and momentum, offering big upside potential. However, it’s critical to approach these trades with the right tools and awareness.

Investors watching marijuana penny stocks should rely on both technical analysis and risk management. Technical charts help identify key support and resistance zones. They also reveal potential entry and exit points based on price action. Because penny stocks can be highly volatile, using stop-loss orders is essential. This helps protect gains and limit downside risk. Traders should also avoid overexposing themselves to one single name. Diversifying across multiple setups spreads out the risk. Monitoring volume spikes, candlestick patterns, and moving averages can provide solid trade signals. While news headlines can trigger quick price moves, technical setups help confirm the timing. When paired together, technical analysis and smart risk control improve your edge. As this sector grows, so does the potential for short-term trades and long-term gains.

Cannabis Market in the U.S.

The cannabis market in the U.S. remains one of the most dynamic sectors for investors. Marijuana penny stocks, in particular, offer the potential for high returns. Though these stocks carry risk, they also allow buying into future market leaders at bargain prices. In April 2025, three companies stand out: Glass House Brands, Cansortium Inc., and Ascend Wellness Holdings. All three are expanding their operations and improving their financials. As legalization efforts continue to gain momentum, these names are worth a closer look.

[Read More]  Starting The Week With Top Marijuana Stocks To Watch Today

Top U.S. Marijuana Penny Stocks to Watch in April 2025

1. Glass House Brands Inc. (OTC: GLASF)
2. Cansortium Inc. (OTC: CNTMF)
3. Ascend Wellness Holdings Inc. (OTC: AAWH)

Glass House Brands Inc.

Glass House Brands is a cannabis company based in California. It operates one of the largest greenhouse cultivation sites in the United States. Its greenhouses span several million square feet. The company produces cannabis at scale while maintaining competitive costs. This allows it to offer affordable products without sacrificing quality.

Glass House operates a total of ten retail locations across California. These dispensaries are well-designed, welcoming, and draw a steady flow of repeat customers. The company also focuses heavily on its in-house brands. These products include cannabis flower, pre-rolls, and other items. The brands are sold both in its own stores and through third-party dispensaries across the state.

California remains the largest legal cannabis market in the world. Glass House has built strong roots in this region. Its large-scale operations give it a unique edge in price, quality, and supply. The company plans to continue expanding in-state in 2025.

Glass House reported strong growth during the last quarter of 2024. Revenue rose steadily compared to the year before. The company improved its gross margins and lowered its production costs. Its ability to produce cannabis cheaply at scale has made a big impact on profits.

The company increased its harvest output while reducing the cost per pound. This combination gave it more room to reinvest and build its brand presence. Gross profit margins remained healthy, and operating income improved. Cash reserves also rose, which boosted investor confidence.

Despite being a penny stock, the company is gaining momentum. If current trends continue, Glass House could break into profitability. Investors are watching closely as it positions itself to lead California’s cannabis scene.

[Read More] Top Canadian Cannabis Stocks to Watch in April 2025

Cansortium Inc.

Cansortium Inc. operates under the Fluent brand. It is a vertically integrated cannabis company with operations in several states. Florida is its largest and most developed market. In Florida alone, the company runs over 30 dispensaries. Additional stores are located in Texas, Pennsylvania, and Michigan.

Cansortium focuses on both cultivation and retail. It grows its own cannabis and sells products in its Fluent stores. The company has built a loyal customer base, especially in the Florida medical market. Products include flower, vapes, capsules, and tinctures.

Its stores are modern and patient-focused, offering a range of product types and dosages. Staff receive regular training and emphasize customer care. This focus has helped Fluent compete with larger multistate operators. Cansortium continues to open new stores and improve its product lines. In 2025, it aims to further expand its presence in existing and new markets.

Financially, Cansortium has seen steady performance improvements. Revenue increased throughout 2024, driven by new dispensary openings. Customer traffic and average transaction values both improved. The company has focused heavily on cost control, resulting in stabilized operating margins.

In recent quarters, the company reported positive adjusted EBITDA. This means it’s generating earnings before taxes and other costs. Cash reserves grew, giving the company a buffer for future expansion. It has also taken steps to improve its balance sheet and manage debt.

With a solid performance in Florida and growth in other states, Consortium has momentum. Its strong customer focus and operational discipline have attracted investors. If legalization expands or regulations ease, the company is well-positioned to scale.

[Read More]  High Potential: U.S. Marijuana Penny Stocks to Watch This April

Ascend Wellness Holdings Inc.

Ascend Wellness is a multi-state cannabis operator based in the United States. The company owns dispensaries and cultivation centers across several key markets. It has operations in Illinois, Michigan, Ohio, Massachusetts, New Jersey, and more. Altogether, Ascend owns nearly 40 retail stores nationwide.

Its largest footprint is in Illinois and New Jersey. These states have seen rapid cannabis market growth. Ascend sells both in-house brands and third-party products. It is known for offering flower, edibles, and vapes at competitive prices.

The company also owns cultivation sites. These facilities grow and process products sold in its stores. Ascend focuses on vertical integration. This means it controls its product from seed to sale. The company continues to open new locations and improve existing ones. It aims to be a dominant player in each of its active markets.

Financial results for Ascend have been mixed, but there are positive signs. The company reported increased revenue over the last few quarters. Retail sales made up the bulk of revenue, showing strong consumer demand.

Wholesale revenue also grew slightly. This reflects Ascend’s ability to sell products to other cannabis businesses. Gross margins remained steady, though operating losses continued. However, the company reported positive adjusted EBITDA. This shows that core business operations are improving.

Ascend also took steps to reduce overhead and improve efficiency. The company cut certain expenses and renegotiated vendor contracts. Cash on hand remained strong, supporting continued expansion plans. Despite some challenges, Ascend is gaining traction.

Its broad state presence, improving operations, and strong retail sales are promising. For investors looking at long-term cannabis plays, Ascend remains one to watch in 2025.

Marijuana Penny Stocks Gaining Momentum in April 2025

The marijuana sector is still evolving, and penny stocks remain a key area of interest. Glass House, Cansortium, and Ascend all offer different approaches to success. One focuses on scale, another on customer loyalty, and the third on state-by-state growth.

These stocks are trading under $1, but each one has the potential to move higher. With expansion plans, improving financials, and favorable market trends, April 2025 could mark a turning point. Investors should always use risk management and research before entering any trade.

The post Undervalued U.S. Cannabis Penny Stocks to Add to Your Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to expand, creating opportunities for investors. In 2024, legal cannabis sales surpassed $30 billion, and analysts expect growth to reach $40 billion by 2025. Several states are pushing for new legalization measures, which could drive more revenue into the sector. Recently, lawmakers have discussed potential federal cannabis reform, including banking access and decriminalization efforts. This news has sparked renewed interest in marijuana penny stocks, which often see high volatility. These low-priced stocks can deliver significant gains but also have higher risks.

Investors should use technical analysis to identify potential entry points before making decisions. Support and resistance levels, moving averages, and trading volume can help confirm price trends. Proper risk management is also essential when trading volatile stocks. Setting stop-loss orders and managing position sizes can help limit losses. As market conditions shift, these penny stocks may offer opportunities for short-term gains in the cannabis sector.

The cannabis industry continues to show resilience despite recent market fluctuations. Many investors are watching for potential growth as legalization efforts progress. The U.S. cannabis market is projected to reach $40 billion by 2025, making it an attractive sector. Companies with strong market positions and expanding operations could see significant gains in the coming months.

This article highlights three top marijuana stocks to watch in March 2025. These companies have notable footprints in the U.S. cannabis industry. They also have strong financials that suggest growth potential. Here’s a closer look at Planet 13 Holdings Inc. (PLNHF), Glass House Brands Inc. (GLASF), and Cresco Labs Inc. (CRLBF).

[Read More] 3 Top Marijuana For Better Trading After Earnings

Top 3 Marijuana Stocks to Watch in March 2025

1. Planet 13 Holdings Inc. (OTC: PLNHF)
2. Glass House Brands Inc. (OTC: GLASF)
3. Cresco Labs Inc. (OTC: CRLBF)

Planet 13 Holdings Inc. (PLNHF)

Planet 13 Holdings Inc. is a well-known cannabis company focusing on superstore dispensaries. It operates some of the largest cannabis retail locations in the U.S. The company is best known for its Las Vegas Superstore, a massive dispensary with an immersive shopping experience.

Besides its flagship location, Planet 13 has expanded to California and Florida. In California, it operates a large dispensary in Santa Ana. The company is also developing additional stores in other high-traffic locations. With plans to expand further, Planet 13 aims to be a leader in the premium cannabis retail market.

Latest Financial Performance

Planet 13 reported strong revenue growth in its latest earnings report. In the most recent quarter, revenue reached $28.5 million, marking an increase from the previous year. This growth was driven by higher foot traffic and increased product offerings.

The company’s gross profit margin improved as well, reaching 50%. This was due to better cost management and strong sales of in-house brands. However, operating expenses remained high due to expansion efforts. Planet 13 continues investing in new locations to strengthen its market position.

Additionally, the company maintains a strong cash position. It holds over $45 million in cash and equivalents, which supports future growth plans. With a focus on innovation and customer experience, Planet 13 remains a stock to watch in the cannabis sector.

[Read More] Top Marijuana Stocks For Investors In The Cannabis Space

Glass House Brands Inc. (GLASF)

Glass House Brands Inc. is one of the largest vertically integrated cannabis operators in California. The company focuses on cultivation, processing, and retail sales. It owns and operates several high-tech greenhouses, producing premium cannabis at low costs.

Glass House’s largest cultivation facility is located in Santa Barbara, California. This greenhouse spans over 5.5 million square feet, making it one of the biggest in the U.S. The company also operates multiple dispensaries, including The Pottery and Farmacy locations. Glass House aims to expand further in California, focusing on low-cost production and high-quality products.

Latest Financial Performance

Glass House Brands recently reported record revenue growth. The company generated $50.2 million in quarterly revenue, representing a 45% year-over-year increase. This growth was fueled by higher production capacity and increasing retail sales.

The company’s gross profit margin also improved, reaching 38%. This was due to its low-cost cultivation strategy, which helps maintain strong profit margins. However, Glass House reported a net loss of $5.2 million, mainly due to expansion costs.

Despite the loss, Glass House remains financially strong. It holds $30 million in cash, providing flexibility for future investments. With its cost-efficient cultivation model, the company is well-positioned for long-term growth. Investors looking for exposure to the California market should keep an eye on this stock.

[Read More]  Top Ancillary Cannabis Stocks for March 2025: Growth Opportunities Ahead

Cresco Labs Inc. (CRLBF)

Cresco Labs Inc. is one of the largest multi-state cannabis operators (MSOs) in the U.S. The company focuses on both retail and wholesale cannabis sales, supplying dispensaries across multiple states. It operates under the Sunnyside brand, which has a strong presence in key markets.

Cresco has over 70 dispensaries in the U.S., with major operations in Illinois, Pennsylvania, and Florida. Illinois remains its largest market, benefiting from strong adult-use sales. The company also owns several cultivation and processing facilities, allowing it to control production costs. With ongoing expansion, Cresco continues to strengthen its market position.

Latest Financial Performance

Cresco Labs recently posted quarterly revenue of $188 million, a 12% increase compared to the previous year. This growth was driven by strong retail performance and expanding wholesale operations. The company remains one of the top-selling brands in the U.S. cannabis market.

The company’s gross profit margin improved to 53%, reflecting better cost management and higher sales volumes. However, net income remains negative, with a reported loss of $9.8 million. The company is working on reducing operational expenses to improve profitability.

Cresco also maintains a solid cash position, with $85 million in cash reserves. This financial stability allows the company to invest in expansion and strategic acquisitions. As one of the leading MSOs in the U.S., Cresco remains a top stock to watch in the cannabis sector.

[Read More] Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

Investing in Cannabis: Strong Financials and Expansion Ahead

The cannabis industry is experiencing renewed interest as legalization efforts progress. Companies with strong market presence and efficient operations are best positioned for growth. Planet 13 Holdings, Glass House Brands, and Cresco Labs are three top stocks to watch in March 2025.

Each company has a unique business model and strong financials, making them attractive investment options. However, the cannabis market remains volatile, so investors should use technical analysis and risk management when considering these stocks. As the industry evolves, these companies could see significant growth in the coming months.

The post March 2025’s Top Cannabis Stocks: Key Players in the Growing Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to experience significant growth, thereby presenting investors with numerous opportunities. Notably, the legal cannabis market added approximately $115.2 billion to the U.S. economy in 2024. Furthermore, projections indicate that legal recreational cannabis sales in the United States are expected to reach nearly $58 billion by 2030. As a result, this robust expansion highlights the sector’s potential, ultimately making it an attractive consideration for investors.

Recent developments in U.S. cannabis legalization have further shaped the industry’s landscape. In New York, authorities have intensified efforts against unlicensed cannabis operations, closing 207 illegal stores. Simultaneously, the number of legal cannabis shops has risen to 307, generating substantial revenue. Additionally, major cannabis companies like Trulieve, Curaleaf, and Green Thumb have introduced hemp-based THC beverages, offering alternative revenue streams amid stalled federal cannabis reforms. These developments underscore the dynamic nature of the cannabis market and the importance of staying informed.

Investing In Top Pot Stocks

Investing in marijuana penny stocks can offer substantial returns but also carries inherent risks. Therefore, employing technical analysis and proper risk management strategies is crucial. Technical analysis involves examining price movements and trading volumes to identify patterns and trends, aiding in making informed investment decisions. Coupled with risk management techniques, such as setting stop-loss orders and diversifying portfolios, investors can better navigate the volatility associated with penny stocks. By staying informed about industry trends and utilizing analytical tools, investors can position themselves to capitalize on opportunities within the burgeoning cannabis sector.

The U.S. cannabis industry continues to flourish, offering investors a plethora of opportunities. This month, three marijuana stocks stand out: Planet 13 Holdings Inc. (PLNH), Cansortium Inc. (CNTMF), and Glass House Brands Inc. (GLASF). Moreover, each company has carved a unique niche in the market, making it worthy of attention.

[Read More] Here Is Why Marijuana Stocks Could See Some Upside This Month

Best U.S. Cannabis Stocks to Watch for the Next Market Rally in 2025

1. Planet 13 Holdings Inc. (OTC: PLNH)
2. Cansortium Inc. (OTC: CNTMF)
3. Glass House Brands Inc. (OTC: GLASF)

Planet 13 Holdings Inc. (PLNH)

Planet 13 Holdings Inc. is a vertically integrated cannabis company based in Nevada. It operates the world’s largest cannabis dispensary, the Planet 13 Cannabis Entertainment Complex, located just off the Las Vegas Strip. This flagship store spans 112,000 square feet and offers customers a unique, immersive experience. Beyond Nevada, Planet 13 has expanded its footprint with Santa Ana, California dispensaries and Waukegan, Illinois. The company also holds a medical marijuana treatment center license in Florida, allowing for statewide expansion. In total, Planet 13 operates 32 dispensaries across the United States.

In the third quarter of 2024, Planet 13 reported revenue of $32.2 million, a 29.7% increase from the same period in the previous year. The company’s gross profit rose by 50.8% year over year to $16.7 million, with a gross margin of 51.9%. Operating expenses decreased by 66.4% to $17.6 million, reflecting strategic cost management. However, the company recorded a net loss of $7.4 million, significantly improving from the $46.3 million loss in Q3 2023. Adjusted EBITDA reached $1.3 million, up from $0.2 million in the previous year, indicating enhanced operational efficiency.

[Read More] Top 3 Cannabis REITs for March 2025: Strong Dividends and Market Expansion

Cansortium Inc. (CNTMF)

Cansortium Inc., operating under the Fluent brand, is a vertically integrated cannabis company headquartered in Miami, Florida. The company focuses on producing and distributing premium medical cannabis products. Its operations are primarily concentrated in Florida, where it has established a strong presence. Cansortium also has operations in Texas, Pennsylvania, and Michigan, aiming to cater to a broad patient base. As of March 2025, the company operates 27 dispensaries in Florida, making it one of the prominent players in the state’s medical cannabis market.

In its latest financial report for the third quarter of 2024, Cansortium reported revenue of $22 million, marking a 15% increase compared to the same quarter in the previous year. The company’s gross profit was $12.5 million, with a gross margin of 56.8%. Operating expenses totaled $10 million, slightly higher than the previous year’s $9.5 million, primarily due to expansion efforts. Net income for the quarter was $1.2 million, a significant improvement from the net loss of $0.8 million reported in Q3 2023. Adjusted EBITDA stood at $5 million, up from $3.5 million in the same period last year, reflecting enhanced operational performance.

[Read More] Investing in Cannabis: Best U.S. Marijuana Stocks to Track in March 2025

Glass House Brands Inc. (GLASF)

Glass House Brands Inc. is a vertically integrated cannabis and hemp company based in California. The company cultivates, manufactures, and distributes cannabis products, focusing on sustainability and quality. Glass House operates several dispensaries across California, including locations in Santa Barbara, Los Angeles, and Berkeley. The company’s cultivation facilities are among the largest in the state, enabling it to produce cannabis at scale. As of March 2025, Glass House operates five dispensaries in California, with plans for further expansion.

In the third quarter of 2024, Glass House reported revenue of $28 million, a 20% increase from the same period in the previous year. The company’s gross profit was $14 million, with a gross margin of 50%. Operating expenses were $12 million, up from $10 million in Q3 2023, reflecting investments in expansion and marketing. The net loss for the quarter was $2 million, an improvement from the $5 million loss reported in the same period last year. Adjusted EBITDA was $6 million, up from $3 million in Q3 2023, indicating improved operational efficiency.

Marijuana Stocks to Watch Now as Legalization Efforts Gain Momentum

Planet 13 Holdings Inc., Cansortium Inc., and Glass House Brands Inc. are three notable U.S. marijuana stocks to watch this month. Each company has demonstrated growth and resilience in the evolving cannabis industry, making them worthy of consideration for investors seeking exposure to this burgeoning market.

The post Top Marijuana Stocks to Watch Now for Potential Growth in 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The U.S. cannabis industry continues to show remarkable growth, with sales projected to reach $41 billion by 2025. This expansion is driven by increasing legalization efforts and rising consumer demand. Notably, over 20 states have legalized recreational cannabis, while more than 30 allow medical use. In recent news, lawmakers are pushing for federal cannabis reform, which could significantly impact the market. Additionally, investor interest in marijuana penny stocks remains high, as these low-cost stocks offer substantial growth potential. Despite their volatility, penny stocks attract traders looking to capitalize on emerging trends in the cannabis sector.

When trading marijuana penny stocks, technical analysis and proper risk management are essential. Traders can identify optimal entry points by analyzing chart patterns and key support and resistance levels. Moreover, using tools like stop-loss orders can help mitigate losses in volatile markets. As legalization expands and the industry matures, these strategies can maximize opportunities while managing risks.

The cannabis industry in the United States has been gaining momentum, with growing legalization and increasing consumer demand. For January 2025, certain marijuana penny stocks are showing strong potential due to their market positioning and innovative strategies. Among them, AYR Wellness Inc. (AYRWF), Cansortium Inc. (CNTMF), and Glass House Brands Inc. (GLASF) stand out. These companies operate in the competitive cannabis space, offering investors an opportunity to explore growth at lower price levels.

[Read More] 3 Marijuana Stocks For Your 2025 Trading List

Top Marijuana Penny Stocks for January 2025

1. AYR Wellness Inc. (OTC: AYRWF)
2. Cansortium Inc. (OTC: CNTMF)
3. Glass House Brands Inc. (OTC: GLASF)

AYR Wellness Inc. (AYRWF)

AYR Wellness is a prominent multi-state operator (MSO) in the cannabis industry. The company operates across several states, including Florida, Pennsylvania, and New Jersey. Florida represents its largest presence, where it owns and operates over 50 dispensaries. AYR Wellness has positioned itself as a leader in high-quality cannabis products, focusing on a wide range of flower, vape, and edible options. Additionally, it emphasizes consumer education and accessibility, further strengthening its foothold in the industry. With legalization expanding, AYR continues to attract attention from investors looking for growth in established and emerging markets.

In its most recent earnings report, AYR Wellness showcased significant revenue growth, driven by its expansion in key states. Quarterly revenues reached $135 million, reflecting a 15% year-over-year increase. However, the company reported a net loss of $5 million, attributed to ongoing operational investments. On the brighter side, adjusted EBITDA was positive, standing at $20 million, indicating improvements in operational efficiency. Additionally, AYR’s management has expressed optimism about 2025, citing Florida’s strong sales and potential new market entries. The company also reduced debt by 8%, enhancing its financial stability. These financial moves signal a commitment to long-term growth and profitability.

[Read More] How Federal Legalization Could Boost Ancillary Cannabis Stocks in 2025

Cansortium Inc. (CNTMF)

Cansortium Inc., also known as Fluent Cannabis Care, is a vertically integrated cannabis company. The company is well-known for its operations in Florida, where it manages over 30 dispensaries. Florida is a crucial market for Cansortium, contributing significantly to its revenue stream. Additionally, Cansortium has operations in Texas, Michigan, and Pennsylvania, making it a regional leader in medicinal cannabis. The company focuses on cultivating premium-quality cannabis products, offering a diverse product line that includes flower, oils, and capsules. With a growing patient base and strategic expansions, Cansortium is poised for continued success.

Cansortium’s recent financial results highlight its steady growth, particularly in Florida. The company reported quarterly revenues of $26 million, marking a 12% increase from the prior year. Gross margins remained strong at 60%, showcasing effective cost management in cultivation and production. Despite these achievements, the company reported a modest net loss of $2 million due to higher administrative expenses. On a positive note, cash flow improved by 10%, supported by increased sales and efficient inventory management. Management has indicated plans to expand dispensaries in Florida while targeting new medicinal markets. These initiatives are expected to drive further growth in 2025.

[Read More] Cannabis Stocks to Watch in 2025: Top Companies and Trading Strategies to Consider

Glass House Brands Inc. (GLASF)

Glass House Brands is a leading California-based cannabis company specializing in large-scale cultivation and retail. The company operates several premium dispensaries across California, its largest market, and manages one of the country’s largest greenhouse cultivation facilities. With an annual production capacity of over 500,000 pounds of cannabis, Glass House emphasizes sustainability and efficiency in its operations. The company’s retail network consists of over 10 dispensaries, including locations in prominent regions like Los Angeles and Santa Barbara. By focusing on high-quality products and customer experience, Glass House Brands continues to capture market share in California’s competitive cannabis market.

In its recent earnings release, Glass House Brands reported strong revenue growth of 20% year-over-year, reaching $35 million. The company attributed this growth to increased cultivation output and higher dispensary sales. Gross margins improved to 50%, reflecting enhanced operational efficiency at its greenhouse facilities. Despite these gains, the company posted a net loss of $4 million, driven by higher marketing and distribution expenses. Glass House is also focused on reducing debt, recently restructuring $15 million in loans to strengthen its financial position. Looking ahead, management is optimistic about capturing more market share as California’s cannabis industry stabilizes.

Best Marijuana Penny Stocks for Short-Term Gains and Long-Term Growth

The cannabis industry is rapidly evolving, offering opportunities for growth and investment. AYR Wellness, Cansortium, and Glass House Brands are positioned to thrive in 2025 due to their market presence, operational strategies, and financial progress. However, it is essential for investors to consider the risks associated with penny stocks, including volatility and regulatory uncertainties. Investors can better navigate this promising sector by using technical analysis and proper risk management. As legalization expands, these companies could see significant upside in the coming years, making them stocks to watch closely this January.

The post Marijuana Penny Stocks to Add to Your Watchlist Today appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..